SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-106351
Filing Date
2021-08-16
Accepted
2021-08-16 16:21:42
Documents
66
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acur-20210630x10q.htm   iXBRL 10-Q 1612797
2 EXHIBIT 31.1 acur-20210630xex31d1.htm EX-31.1 14767
3 EXHIBIT 31.2 acur-20210630xex31d2.htm EX-31.2 14164
4 EXHIBIT 32.1 acur-20210630xex32d1.htm EX-32.1 9912
  Complete submission text file 0001104659-21-106351.txt   6753563

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA acur-20210630.xsd EX-101.SCH 46800
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acur-20210630_cal.xml EX-101.CAL 39683
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acur-20210630_def.xml EX-101.DEF 194118
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20210630_lab.xml EX-101.LAB 346837
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20210630_pre.xml EX-101.PRE 343599
10 EXTRACTED XBRL INSTANCE DOCUMENT acur-20210630x10q_htm.xml XML 1237065
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10113 | Film No.: 211178584
SIC: 2834 Pharmaceutical Preparations